The Economist.
I mean historically China was behind, way behind.
It's gradually changing.
This is Wang Shingli.
And he's pretty excited about where his industry is heading.
If say US does not maintain its speed in science,
it probably will going to be behind when China's continue to support this kind of development.
But he's not talking about AI, or batteries, or even electric vehicles.
He's talking about medicines.
Western firms have long dominated the pharmaceutical industry.
Pfizer, Eli Lilly, AstraZeneca, they're household names.
But now, Chinese pharma is catching up.
And with America's president hardly a friend to the industry.
We're going to get the drug prices down, not 30 or 40%.
No, we're going to get them down 1,000%, 600%, 500%.
Some of the world's biggest drug companies are looking to China,
not for the cheap generics they've been known for, but to develop new cures.
I'm Jeremy Page, The Economist's chief China correspondent,
and today I'm joined by our global business writer, Shailesh Chitnis, to ask,
are China's medicines about to take over the world?